|Bid||616.25 x 0|
|Ask||616.45 x 0|
|Day's range||615.05 - 624.25|
|52-week range||212.70 - 624.25|
|Beta (5Y monthly)||N/A|
|PE ratio (TTM)||47.58|
|Forward dividend & yield||N/A (N/A)|
|1y target est||444.39|
New Delhi, Jun 24 (PTI) Drug firm Zydus Cadila on Thursday said it has received tentative approval from the US health regulator to market Fingolimod capsules, used in the treatment of multiple sclerosis, in the American market.
New Delhi, Jun 21 (PTI) Cadila Healthcare and Bayer (South East Asia) have decided to extend the operations of their joint venture by three years with effect from June, the companies said in a joint statement on Monday.
New Delhi, Jun 14 (PTI) Zydus Cadila on Monday said it has received tentative approval from the US health regulator to market epilepsy treatment drug Brivaracetam tablets.